Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 53

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 53
---
 |             |                               1,419 |     |                    | 1,002 |   |     |         | 436 |   |
| Financial income, net               |     |                       |                       (25 | ) |     |             |                                   2 |     |                    |   (15 | ) |     |         |   * | ) |
| Net loss and comprehensive loss     |     |                       |                       770 |   |     |             |                               1,421 |     |                    |   987 |   |     |         | 436 |   |

| *) | less than 1 thousand |

We have prepared our discussion of the results of operations by comparing the results of the combined Successor period from July 24, 2024 through September 30, 2024 and from January 1, 2024 through July 23, 2024 the Predecessor period for the years ended December 31, 2023 and December 31, 2022.

We believe this approach provides the most meaningful basis of comparison and is more useful in identifying current business trends for the periods presented. The combined results of operations included in our discussion below are not considered to be prepared in accordance with U.S. GAAP and have not been prepared as pro forma results under applicable regulations, may not reflect the actual results we would have achieved had the Business Combination occurred at the beginning of fiscal 2024, and should not be viewed as a substitute for the results of operations of the Predecessor and Successor periods presented in accordance with U.S. GAAP.

<div align='center'>32</div>

Comparison of the period commencing July 24, 2024 through September 30, 2024 (Successor and Predecessor) to the period commencing July 24, 2024 through September 30, 2024 (Predecessor)

The following table is data derived from the Consolidated Statement of Operations (in thousands) and the discussions that follow are in approximate amounts.

|                                     |     | Successor and Predecessor |     |   |     |                       Predecessor |     |
|                                     |     |                   For the 
 period commencing July 24 |     |   |     | For the period commencing July 24 |     |
|                                     |     |      through September 30 |     |   |     |              through September 30 |     |
|                                     |     |                      2024 |     |   |